Reciprocal interactions between beta1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: a different perspective in epithelial biology.

Anchorage and growth factor independence are cardinal features of the transformed phenotype. Although it is logical that the two pathways must be coregulated in normal tissues to maintain homeostasis, this has not been demonstrated directly. We showed previously that down-modulation of beta1-integrin signaling reverted the malignant behavior of a human breast tumor cell line (T4-2) derived from phenotypically normal cells (HMT-3522) and led to growth arrest in a three-dimensional (3D) basement membrane assay in which the cells formed tissue-like acini (14). Here, we show that there is a bidirectional cross-modulation of beta1-integrin and epidermal growth factor receptor (EGFR) signaling via the mitogen-activated protein kinase (MAPK) pathway. The reciprocal modulation does not occur in monolayer (2D) cultures. Antibody-mediated inhibition of either of these receptors in the tumor cells, or inhibition of MAPK kinase, induced a concomitant down-regulation of both receptors, followed by growth-arrest and restoration of normal breast tissue morphogenesis. Cross-modulation and tissue morphogenesis were associated with attenuation of EGF-induced transient MAPK activation. To specifically test EGFR and beta1-integrin interdependency, EGFR was overexpressed in nonmalignant cells, leading to disruption of morphogenesis and a compensatory up-regulation of beta1-integrin expression, again only in 3D. Our results indicate that when breast cells are spatially organized as a result of contact with basement membrane, the signaling pathways become coupled and bidirectional. They further explain why breast cells fail to differentiate in monolayer cultures in which these events are mostly uncoupled. Moreover, in a subset of tumor cells in which these pathways are misregulated but functional, the cells could be "normalized" by manipulating either pathway.

[1]  S. Okamoto,et al.  Evidence for physiological function of epidermal growth factor: pregestational sialoadenectomy of mice decreases milk production and increases offspring mortality during lactation period. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[2]  J. Massagué,et al.  Regulation of cell adhesion receptors by transforming growth factor-beta. Concomitant regulation of integrins that share a common beta 1 subunit. , 1989, The Journal of biological chemistry.

[3]  A. Horwitz,et al.  Identification of amino acid sequences in the integrin beta 1 cytoplasmic domain implicated in cytoskeletal association , 1992, The Journal of cell biology.

[4]  P. Briand,et al.  Altered gene expression of c-myc, epidermal growth factor receptor, transforming growth factor-alpha, and c-erb-B2 in an immortalized human breast epithelial cell line, HMT-3522, is associated with decreased growth factor requirements. , 1992, Cancer research.

[5]  M. Bissell,et al.  Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[6]  M. Shoyab,et al.  Amphiregulin induces tyrosine phosphorylation of the epidermal growth factor receptor and p185erbB2. Evidence that amphiregulin acts exclusively through the epidermal growth factor receptor at the surface of human epithelial cells. , 1993, The Journal of biological chemistry.

[7]  Y. Takada,et al.  Identification of a regulatory region of integrin beta 1 subunit using activating and inhibiting antibodies. , 1993, The Journal of biological chemistry.

[8]  M. Kinch,et al.  Integrin-mediated cell adhesion activates mitogen-activated protein kinases. , 1994, The Journal of biological chemistry.

[9]  C. Arteaga,et al.  Epidermal growth factor receptors in human breast carcinoma cells: a potential selective target for transforming growth factor alpha-Pseudomonas exotoxin 40 fusion protein. , 1994, Cancer research.

[10]  K. Lim,et al.  Integrin switching regulates normal trophoblast invasion. , 1994, Development.

[11]  G. Johnson,et al.  Sequential protein kinase reactions controlling cell growth and differentiation. , 1994, Current opinion in cell biology.

[12]  D. Mischoulon,et al.  Cell-extracellular matrix interactions can regulate the switch between growth and differentiation in rat hepatocytes: reciprocal expression of C/EBP alpha and immediate-early growth response transcription factors , 1994, Molecular and cellular biology.

[13]  M J Bissell,et al.  A hierarchy of ECM-mediated signalling regulates tissue-specific gene expression. , 1995, Current opinion in cell biology.

[14]  C. Marshall,et al.  Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation , 1995, Cell.

[15]  G. Mann,et al.  A mutation in the epidermal growth factor receptor in waved-2 mice has a profound effect on receptor biochemistry that results in impaired lactation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. Brugge,et al.  Integrins and signal transduction pathways: the road taken. , 1995, Science.

[17]  J. Parsons,et al.  Signal transduction through integrins: A central role for focal adhesion kinase? , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.

[18]  Zoltan Kiss,et al.  The bisindolylmaleimide GF 109203X, a selective inhibitor of protein kinase C, does not inhibit the potentiating effect of phorbol ester on ethanol-induced phospholipase C-mediated hydrolysis of phosphatidylethanolamine. , 1995, Biochimica et biophysica acta.

[19]  M. Bissell,et al.  From laminin to lamin: regulation of tissue-specific gene expression by the ECM. , 1995, Trends in cell biology.

[20]  R. Lupu,et al.  Interaction between erbB-receptors and heregulin in breast cancer tumor progression and drug resistance. , 1995, Seminars in cancer biology.

[21]  A. Saltiel,et al.  Targeting signal transduction in the discovery of antiproliferative drugs. , 1996, Chemistry & biology.

[22]  S. Dedhar,et al.  Regulation of cell adhesion and anchorage-dependent growth by a new β1-integrin-linked protein kinase , 1996, Nature.

[23]  W. Cavenee,et al.  Tyrphostin AG 1478 preferentially inhibits human glioma cells expressing truncated rather than wild-type epidermal growth factor receptors. , 1996, Cancer research.

[24]  E. Ruoslahti,et al.  Control of adhesion-dependent cell survival by focal adhesion kinase , 1996, The Journal of cell biology.

[25]  A. Horwitz,et al.  Adhesion-growth factor interactions during differentiation: an integrated biological response. , 1996, Developmental biology.

[26]  H. Scher,et al.  Anti-epidermal growth factor receptor monoclonal antibody 225 up-regulates p27KIP1 and induces G1 arrest in prostatic cancer cell line DU145. , 1996, Cancer research.

[27]  R. Hynes,et al.  Ras Activation Is Necessary for Integrin-mediated Activation of Extracellular Signal-regulated Kinase 2 and Cytosolic Phospholipase A2 but Not for Cytoskeletal Organization* , 1996, The Journal of Biological Chemistry.

[28]  B. Gumbiner,et al.  Cell Adhesion: The Molecular Basis of Tissue Architecture and Morphogenesis , 1996, Cell.

[29]  O. Petersen,et al.  Trisomy 7p and malignant transformation of human breast epithelial cells following epidermal growth factor withdrawal. , 1996, Cancer research.

[30]  C. Larabell,et al.  Reversion of the Malignant Phenotype of Human Breast Cells in Three-Dimensional Culture and In Vivo by Integrin Blocking Antibodies , 1997, The Journal of cell biology.

[31]  F. Giancotti,et al.  Integrin signaling: specificity and control of cell survival and cell cycle progression. , 1997, Current opinion in cell biology.

[32]  Opioid Peptide Gene Expression in the Primary Hereditary Cardiomyopathy of the Syrian Hamster , 1997, The Journal of Biological Chemistry.

[33]  M. Schwartz.  Integrins, Oncogenes, and Anchorage Independence , 1997, The Journal of cell biology.

[34]  G. Nuovo,et al.  Hyperexpression of mitogen-activated protein kinase in human breast cancer. , 1997, The Journal of clinical investigation.

[35]  Kenneth M. Yamada,et al.  Integrins in morphogenesis and signaling. , 1997, Biochimie.

[36]  H. Wiley,et al.  The Enhanced Tumorigenic Activity of a Mutant Epidermal Growth Factor Receptor Common in Human Cancers Is Mediated by Threshold Levels of Constitutive Tyrosine Phosphorylation and Unattenuated Signaling* , 1997, The Journal of Biological Chemistry.

[37]  S. Dedhar,et al.  Overexpression of the Integrin-linked Kinase Promotes Anchorage-independent Cell Cycle Progression* , 1997, The Journal of Biological Chemistry.

[38]  J. Woodgett,et al.  Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[39]  E. Mccleskey,et al.  Rap1 mediates sustained MAP kinase activation induced by nerve growth factor , 1998, Nature.

[40]  Wang et al. , 2021 .